Reviva Pharmaceuticals' brilaroxazine shows promise for schizophrenia, but regulatory and financial risks persist. Read why ...

A research team led by Dr Brian Chung Hon-yin (third left) has revealed that individuals who experienced childhood maltreatment face markedly elevated ...

Schizophrenia has long been framed as a disorder of broken thoughts and fractured perception, but a new line of research ...

Olanzapine long-acting injectable (LAI) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation, for a ...

New research from the Institute of Psychiatry, Psychology & Neuroscience, supported by the Population Mental Health ...

People living with schizophrenia continue to battle not just their symptoms, delayed diagnoses and access to quality healthcare, but also the societal demons of misinformation, stigma and deep-rooted ...

New findings suggest that doxycycline, often used for acne, may lower the long-term risk of schizophrenia in vulnerable adolescents. The study, based on more than 56,000 youth medical records, shows a ...

People with schizophrenia often take strong antipsychotics that control symptoms but frequently cause rapid weight gain, high blood sugar, and a ...

Cobenfy’s efficacy at treating the symptoms of patients with psychosis may vary between subgroups, according to a post-hoc ...

Directed by Eric Lin, this downbeat, superbly acted drama presents a family in crisis and a worried mother who contemplates ...

Many people live with a secret that feels almost impossible to describe. They hear speech or whispers that nobody else detects. These are not vague impressions. They can feel as solid as a friend ...

The marijuana industry has sold us a bill of goods, and we’ve given ourselves over to a mass mania, disregarding scientific ...